The impact of aspirin use on outcomes in patients with inflammatory bowel disease: Insights from a national database.

ABSTRACT:

Background

Inflammatory bowel disease (IBD) is an inflammatory disorder that can increase the risk of mortality. Aspirin is an anti-inflammatory drug used for primary prevention of cardiovascular events. A single center analysis previously reported that aspirin use did not impact major outcomes in IBD. In this study, we aim to assess the impact of aspirin use on mortality and other outcomes in patients with IBD using national data.

Methods

National inpatient sample (NIS) 2016-2020 was used to identify adult patients with IBD. Data were collected on patient demographics, hospital characteristics, and comorbidities. The outcomes studied were in-hospital mortality, sepsis, shock, Intensive Care Unit (ICU) admission, and need for surgery. Multivariate logistic regression analysi

SUBMITTER: Iqbal H 

PROVIDER: S-EPMC10733222 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature